Lux Biosciences' LX-211 granted fast track designation for the treatment of uveitis Aug. 8, 2007 No Comments
Bausch & Lomb Ireland withdraws Retisert marketing authorization application July 27, 2007 No Comments
Preclinical antiglaucomal efficacy of the novel prostanoid FP receptor agonist tafluprost presented July 24, 2007 No Comments
RSS